[
    {
        "nlp_output": {
            "annotations": [
                {
                    "concept_class": "lab",
                    "concept_confidence": 0.95,
                    "concept_mention_string": "hemoglobin",
                    "controlled_vocabulary_concept_identifier": "",
                    "controlled_vocabulary_concept_official_term": "",
                    "controlled_vocabulary_namespace": "none",
                    "controlled_vocabulary_source": "original",
                    "controlled_vocabulary_version": "",
                    "dt4h_concept_identifier": "38082009",
                    "end_offset": 2896,
                    "negation": "no",
                    "negation_confidence": 1.0,
                    "nel_component_type": "DT4H",
                    "nel_component_version": "2024-06-01",
                    "ner_component_type": "dictionary lookup",
                    "ner_component_version": "3.8.0",
                    "qualifier_negation": "",
                    "qualifier_temporal": "",
                    "start_offset": 2886
                },
                {
                    "concept_class": "signs and symptoms",
                    "concept_confidence": 0.95,
                    "concept_mention_string": "tachykardie",
                    "controlled_vocabulary_concept_identifier": "",
                    "controlled_vocabulary_concept_official_term": "",
                    "controlled_vocabulary_namespace": "none",
                    "controlled_vocabulary_source": "original",
                    "controlled_vocabulary_version": "",
                    "dt4h_concept_identifier": "3424008",
                    "end_offset": 4056,
                    "negation": "no",
                    "negation_confidence": 1.0,
                    "nel_component_type": "DT4H",
                    "nel_component_version": "2024-06-01",
                    "ner_component_type": "dictionary lookup",
                    "ner_component_version": "3.8.0",
                    "qualifier_negation": "",
                    "qualifier_temporal": "",
                    "start_offset": 4045
                },
                {
                    "concept_class": "lab",
                    "concept_confidence": 0.95,
                    "concept_mention_string": "drasl\u00edk",
                    "controlled_vocabulary_concept_identifier": "",
                    "controlled_vocabulary_concept_official_term": "",
                    "controlled_vocabulary_namespace": "none",
                    "controlled_vocabulary_source": "original",
                    "controlled_vocabulary_version": "",
                    "dt4h_concept_identifier": "88480006",
                    "end_offset": 4619,
                    "negation": "no",
                    "negation_confidence": 1.0,
                    "nel_component_type": "DT4H",
                    "nel_component_version": "2024-06-01",
                    "ner_component_type": "dictionary lookup",
                    "ner_component_version": "3.8.0",
                    "qualifier_negation": "",
                    "qualifier_temporal": "",
                    "start_offset": 4612
                },
                {
                    "concept_class": "cv diseases",
                    "concept_confidence": 0.95,
                    "concept_mention_string": "kardiomyopatie",
                    "controlled_vocabulary_concept_identifier": "",
                    "controlled_vocabulary_concept_official_term": "",
                    "controlled_vocabulary_namespace": "none",
                    "controlled_vocabulary_source": "original",
                    "controlled_vocabulary_version": "",
                    "dt4h_concept_identifier": "85898001",
                    "end_offset": 5263,
                    "negation": "no",
                    "negation_confidence": 1.0,
                    "nel_component_type": "DT4H",
                    "nel_component_version": "2024-06-01",
                    "ner_component_type": "dictionary lookup",
                    "ner_component_version": "3.8.0",
                    "qualifier_negation": "",
                    "qualifier_temporal": "",
                    "start_offset": 5249
                }
            ],
            "processing_success": true,
            "record_metadata": {
                "admission_id": 6231,
                "clinical_site_id": 9839,
                "deidentification_pipeline_name": "",
                "deidentification_pipeline_version": "",
                "deidentified": "no",
                "nlp_processing_date": "2025-03-06T17:01:27.144696",
                "nlp_processing_pipeline_name": "DictionaryLookupModel",
                "nlp_processing_pipeline_version": "1.0",
                "patient_id": 8105,
                "record_character_encoding": "UTF-8",
                "record_creation_date": "2025-03-04 15:43:43.991395",
                "record_extraction_date": "2025-03-06T17:01:27.144692",
                "record_format": "json",
                "record_id": "36042600",
                "record_lastupdate_date": "2025-03-06T17:01:27.144678",
                "record_type": 32817,
                "report_language": "cs",
                "report_section": "Radiology Report",
                "text": "56let\u00fd mu\u017e o hmotnosti 90 kg s anamn\u00e9zou hypertenze a poruchy u\u017e\u00edv\u00e1n\u00ed alkoholu, bez anamn\u00e9zy diabetu, se dostavil na pohotovostn\u00ed odd\u011blen\u00ed s progreduj\u00edc\u00ed du\u0161nost\u00ed a otoky doln\u00edch kon\u010detin, kter\u00fdch si poprv\u00e9 v\u0161iml po j\u00edzd\u011b na kole. Byla u n\u011bj zji\u0161t\u011bna fibrilace s\u00edn\u00ed s rychlou komorovou odpov\u011bd\u00ed. Dekompenzoval se po pod\u00e1n\u00ed intraven\u00f3zn\u00edho diltiazemu na odd\u011blen\u00ed urgentn\u00edho p\u0159\u00edjmu. Vy\u017eadoval mechanickou ventilaci pro plicn\u00ed ed\u00e9m a byl podporov\u00e1n \u010detn\u00fdmi vazopresory pro kardiogenn\u00ed \u0161ok (ejek\u010dn\u00ed frakce [EF] lev\u00e9 komory [LK] < 20 %). Byl p\u0159evezen na katetrizaci lev\u00e9ho srdce, kter\u00e1 neprok\u00e1zala obstruk\u010dn\u00ed onemocn\u011bn\u00ed koron\u00e1rn\u00edch tepen. Pot\u00e9 mu bylo p\u0159es axil\u00e1rn\u00ed tepnu zavedeno perkut\u00e1nn\u00ed asisten\u010dn\u00ed za\u0159\u00edzen\u00ed pro levou srde\u010dn\u00ed komoru (Impella\u00ae). Femor\u00e1ln\u00ed VA-ECMO bylo p\u0159id\u00e1no z d\u016fvodu \u0161patn\u00fdch pr\u016ftok\u016f asisten\u010dn\u00edm za\u0159\u00edzen\u00edm lev\u00e9 komory a klinick\u00e9ho zhor\u0161en\u00ed v d\u016fsledku biventrikul\u00e1rn\u00edho srde\u010dn\u00edho selh\u00e1n\u00ed a plicn\u00edho ed\u00e9mu. S kardiogenn\u00edm \u0161okem a multisyst\u00e9mov\u00fdm org\u00e1nov\u00fdm selh\u00e1n\u00edm byl p\u0159elo\u017een do na\u0161\u00ed nemocnice k dal\u0161\u00edmu \u0159e\u0161en\u00ed.\n\nPo 8 dnech t\u00e9to mechanick\u00e9 a mimot\u011bln\u00ed podpory, v\u010detn\u011b kontinu\u00e1ln\u00ed n\u00e1hradn\u00ed l\u00e9\u010dby ledvin, se u n\u011bj objevilo krv\u00e1cen\u00ed v okol\u00ed ECMO kanyl a ipsilater\u00e1ln\u00ed ischemie doln\u00edch kon\u010detin. Vzhledem k nov\u00fdm komplikac\u00edm a n\u011bkolikan\u00e1sobn\u00fdm pokus\u016fm o r\u016fzn\u00e9 d\u00e1vky vazopresor\u016f a pokus\u016fm o odpojen\u00ed byl pova\u017eov\u00e1n za maxim\u00e1ln\u011b optimalizovan\u00e9ho pro dekanylaci VA-ECMO. Pro zaji\u0161t\u011bn\u00ed co nejkontrolovan\u011bj\u0161\u00edho prost\u0159ed\u00ed a maxim\u00e1ln\u00edho pom\u011bru l\u00e9ka\u0159e a sestry k pacientovi bylo konzultov\u00e1no s toxikologem pou\u017eit\u00ed HDI intraopera\u010dn\u011b jako dopl\u0148kov\u00e9 inotropn\u00ed l\u00e9\u010dby b\u011bhem dekanylace. Den p\u0159ed dekanylac\u00ed transtorak\u00e1ln\u00ed echokardiografie (TTE) odhalila norm\u00e1ln\u00ed velikost dutiny LK a tlou\u0161\u0165ku st\u011bny s v\u00fdrazn\u011b sn\u00ed\u017eenou systolickou funkc\u00ed a EF <10 % b\u011bhem odpojen\u00ed od ECMO a\u017e na 1 l/min p\u0159i maxim\u00e1ln\u00ed podpo\u0159e Impella\u00ae (nastaven\u00ed P-9, co\u017e znamen\u00e1 33 000 ot\u00e1\u010dek za minutu). Byla zaznamen\u00e1na m\u00edrn\u00e1 a\u017e st\u0159edn\u011b t\u011b\u017ek\u00e1 systolick\u00e1 dysfunkce prav\u00e9 komory (RV) spolu s t\u011b\u017ekou glob\u00e1ln\u00ed hypokinez\u00ed. Nejni\u017e\u0161\u00ed glykemie, kterou m\u011bl v p\u0159edchoz\u00edch 7 dnech, byla 120 mg/dl a v p\u0159edchoz\u00edch 5 dnech 160 mg/dl. Den p\u0159ed dekanylac\u00ed m\u011bl glyk\u00e9mii 250 mg/dl a r\u00e1no p\u0159ed dekanylac\u00ed m\u011bl glyk\u00e9mii 227 mg/dl.\n\nIntraopera\u010dn\u011b byl b\u011bhem dekanylace monitorov\u00e1n transezofage\u00e1ln\u00ed echokardiografi\u00ed (TEE) v re\u00e1ln\u00e9m \u010dase. Na za\u010d\u00e1tku z\u00e1kroku byla p\u0159\u00edtomna t\u011b\u017ek\u00e1 biventrikul\u00e1rn\u00ed dysfunkce, p\u0159i\u010dem\u017e LVEF byla vizu\u00e1ln\u011b odhadnuta na 10-15 %, zat\u00edmco byl na 14 \u03bcg/min noradrenalinu a 3 \u03bcg/min adrenalinu. Zobrazte funkci LK na za\u010d\u00e1tku a na konci systoly v transverz\u00e1ln\u00edm zobrazen\u00ed v kr\u00e1tk\u00e9 ose. Dvacet minut p\u0159ed dekanylac\u00ed byl pod\u00e1n b\u011b\u017en\u00fd bolus inzulinu 1 U/kg s 25 g dextr\u00f3zy a byla zah\u00e1jena infuze inzulinu 1 U/kg/hod. Opakovan\u00e1 TEE p\u0159ed dekanylac\u00ed uk\u00e1zala funkci LK 30-40 % s v\u00fdrazn\u011b zlep\u0161enou funkc\u00ed RV. B\u011bhem z\u00e1kroku dostal 3 jednotky balen\u00fdch \u010derven\u00fdch krvinek, aby se nahradil objem ztracen\u00fd v ECMO okruhu p\u0159i dekanylaci. Jeho hemoglobin byl 2 hodiny p\u0159ed dekanalizac\u00ed 10,6 g/dl a 1 hodinu po dekanylaci 11,5 g/dl. Po dekanylaci, p\u0159i st\u0159edn\u00edm arteri\u00e1ln\u00edm tlaku 60 a\u017e 70 mm Hg, za\u010dala jeho pulzn\u00ed oxymetrie m\u00edt klesaj\u00edc\u00ed tendenci s nadirem 60 %, a to i p\u0159es optimalizaci ventila\u010dn\u00edho nastaven\u00ed (100 % frakce inspirovan\u00e9ho kysl\u00edku a pozitivn\u00ed end-expira\u010dn\u00ed tlak 14 mm Hg) a tak\u00e9 zkou\u0161ku re\u017eimu inverzn\u00edho ventila\u010dn\u00edho pom\u011bru. Plynov\u00e1 anal\u00fdza arteri\u00e1ln\u00ed krve uk\u00e1zala pH 7,23, pCO2 59 mm Hg a pO2 39 mm Hg. Byla pod\u00e1na bolusov\u00e1 d\u00e1vka milrinonu 50 \u03bcg/kg. N\u00e1sledovala inhalace oxidu dusnat\u00e9ho ke sn\u00ed\u017een\u00ed plicn\u00ed c\u00e9vn\u00ed rezistence, infuze vazopresinu k potla\u010den\u00ed syst\u00e9mov\u00e9 vazodilatace zp\u016fsoben\u00e9 milrinonem a zv\u00fd\u0161en\u00ed infuze adrenalinu a noradrenalinu na 8, resp. 14 \u03bcg/min. SpO2 se zlep\u0161ila na 100 % 15 minut po bolusov\u00e9 d\u00e1vce milrinonu. PA tlak p\u0159ed dekanylac\u00ed byl 5 mm Hg, zat\u00edmco po t\u011bchto intervenc\u00edch byl 35 mm Hg. Infuze milrinonu byla zah\u00e1jena d\u00e1vkou 0,25 \u03bcg/kg/hod. Pacientovi byla sn\u00ed\u017eena d\u00e1vka epinefrinu z 8 \u03bcg/min na 4 \u03bcg/min a noradrenalinu ze 14 \u03bcg/min na 8 \u03bcg/min.\n\nOpakovan\u00e1 TEE prok\u00e1zala trvale zlep\u0161enou funkci LK, proto byl epinefrin vysazen kv\u016fli epizod\u00e1m supraventrikul\u00e1rn\u00ed tachykardie. Infuze milrinonu byla n\u00e1sledn\u011b zastavena a na jednotce intenzivn\u00ed p\u00e9\u010de byl zv\u00fd\u0161en noradrenalin. TTE 3,5 hodiny po bolusu HDI, kdy u\u017e\u00edval 1 U/kg/hod HDI, 18 \u03bcg/min noradrenalinu, 0,04 U vazopresinu a inhala\u010dn\u00ed oxid dusnat\u00fd, odhalilo norm\u00e1ln\u00ed systolickou funkci LK s EF 50-55 % a m\u00edrn\u011b sn\u00ed\u017eenou systolickou funkci RV. Infuze HDI pokra\u010dovala 24 hodin po bolusu. Po\u010d\u00e1te\u010dn\u00ed glyk\u00e9mie po bolusu dextr\u00f3zy byla 488 mg/dl. Infuze dextr\u00f3zy byla zah\u00e1jena 5 hodin po bolusu HDI, titrovan\u00e1 na glyk\u00e9mii > 150 mg/dl, rychlost\u00ed 0,33 a\u017e 0,5 g/kg/hod. P\u0159ed bolusem HDI m\u011bl drasl\u00edk 3,6 mEq/l a jeho nadir byl 3,2 mEq/l 12 hodin po bolusu HDI. P\u0159ed zastaven\u00edm infuze inzulinu dostal pouze 1 d\u00e1vku 30 mmol/l fosfore\u010dnanu draseln\u00e9ho v celkov\u00e9m exogenn\u00edm drasl\u00edku. Po zastaven\u00ed infuze inzulinu pokra\u010dovala infuze dextr\u00f3zy po dobu 24 hodin a bylo pod\u00e1no dal\u0161\u00edch 30 mmol/l kaliumfosf\u00e1tu. Jeho glyk\u00e9mie den po dekanylaci byla 181 mg/dl.\n\nStav pacienta se v pr\u016fb\u011bhu n\u011bkolika n\u00e1sleduj\u00edc\u00edch t\u00fddn\u016f d\u00e1le zlep\u0161oval a po 6 dnech do\u0161lo k extubaci. Hodnota hemoglobinu A1C 21 dn\u00ed po dekanylaci byla 5,2 %. Nakonec byl 26 dn\u00ed po dekanylaci ECMO propu\u0161t\u011bn dom\u016f se zaji\u0161t\u011bnou ambulantn\u00ed terapi\u00ed s diagn\u00f3zou dilata\u010dn\u00ed neischemick\u00e9 kardiomyopatie bez potvrzen\u00e9 etiologie. P\u0159i kontrole v kardiologick\u00e9 ambulanci o 2 t\u00fddny pozd\u011bji byl bd\u011bl\u00fd a orientovan\u00fd bez lo\u017eiskov\u00e9ho neurologick\u00e9ho deficitu. Po 6 m\u011bs\u00edc\u00edch podstoupil opakovan\u00e9 TTE, kter\u00e9 prok\u00e1zalo LVEF 15-20 %, v\u00fdrazn\u011b sn\u00ed\u017een\u00fd RVEF a glob\u00e1ln\u00ed hypokinezi, ale obnovil sv\u00e9 aktivity, v\u010detn\u011b j\u00edzdy na kole 10 mil denn\u011b v p\u0159\u00edrod\u011b.\n\n"
            }
        },
        "nlp_service_info": {
            "service_app_name": "DT4H NLP Processor",
            "service_language": "cs",
            "service_model": "DictionaryLookupModel",
            "service_version": "1.0"
        }
    }
]